Clinical News: Page 1708

Navidea submits Lymphoseek application to EMA
By AuntMinnie.com staff writers
Radiopharmaceutical developer Navidea Biopharmaceuticals has submitted a marketing authorization application (MAA) to the European Medicines Agency (EMA) for its investigational radiopharmaceutical Lymphoseek injection, an intraoperative lymphatic mapping agent.
December 18, 2012
iPad turns in mixed results for chest radiographs
By Erik L. Ridley
The iPad appears capable of supporting the diagnosis of pneumothorax on chest radiographs, according to an initial evaluation of an iOS-based image viewing app developed by a team from Massachusetts General Hospital. The group also found that its app, at least for now, didn't fare as well in cases with nonpneumothorax findings.
December 18, 2012
Chartrounds offers expert advice to radiation oncologists
By Cynthia E. Keen
Where can radiation oncologists working in community hospitals get advice or feedback about a treatment plan for a patient? If they have an Internet connection, they can join Chartrounds, a virtual networking site that links radiation therapy luminaries with any practicing radiation oncologist in the world.
December 18, 2012
2012 12 14 11 08 49 891 Hardenbergh Patricia 70
CMS may loosen PET rules; ACR Select makes progress; CT radiation risk
By Brian Casey
December 17, 2012
Carestream wins Neb. contract
By AuntMinnie.com staff writers
Carestream Health has won a contract with a Nebraska medical center for 15 of its DRX digital radiography systems.
December 17, 2012
GE, Merck ink deal on PET biomarker research
By AuntMinnie.com staff writers
GE Healthcare and pharmaceutical firm Merck have announced that they will collaborate on imaging biomarker research.
December 17, 2012
MITA lauds CMS PET tracer proposal
By AuntMinnie.com staff writers
The Medical Imaging and Technology Alliance (MITA) is lauding the proposal by the U.S. Centers for Medicare and Medicaid Services (CMS) to remove the national noncoverage decision for PET with radiopharmaceuticals for U.S. Food and Drug Administration-approved oncologic applications.
December 17, 2012
Study finds CT radiation risk may be overestimated
By Eric Barnes
The risks from testicular cancer far outweigh the radiation risk from CT exams used to diagnose and monitor it, concludes a study published today in Radiology. While the study was limited to testicular cancer, it illustrates a common mistake being made in estimating the risk of radiation from medical imaging exams.
December 17, 2012
Accuray installs 1st CyberKnife in Venezuela
By AuntMinnie.com staff writers
Radiation oncology firm Accuray announced that Hospital Dr. Domingo Luciani in Caracas is the first hospital in Venezuela to use its CyberKnife robotic radiosurgery system.
December 17, 2012
Is proton therapy worth the cost for prostate cancer?
By Cynthia E. Keen
Is the use of proton therapy for localized prostate cancer worth the cost? A national study of 30,000 men suggests it might not be. Findings were published online December 14 in the Journal of the National Cancer Institute.
December 16, 2012
Elekta gets FDA OK for monitoring software
By AuntMinnie.com staff writers
Radiation oncology firm Elekta has received U.S. Food and Drug Administration 510(k) clearance for its Clarity 4D monitoring software, which monitors motion in the prostate and surrounding tissues and organs during radiation therapy for prostate cancer.
December 16, 2012
Low-dose CT raises coronary calcium scores; IR corrects them
By Eric Barnes
Low-dose coronary artery calcium (CAC) scores are reliable if iterative reconstruction (IR) is applied to the CT data, according to research presented at RSNA 2012. Dutch researchers found that the technology ensures the accuracy of CAC scores that would otherwise be higher and less predictable than the results of higher-dose CT scans.
December 16, 2012
2012 12 14 14 53 58 426 Calciumscore 70
Previous Page
Page 1708 of 3660
Next Page